Literature DB >> 15634883

Autocrine regulation of T cell motility by calreticulin-thrombospondin-1 interaction.

Shu Shun Li1, Anna Forslöw, Karl-Gösta Sundqvist.   

Abstract

The mechanisms regulating T lymphocyte migration within the extracellular matrix are not understood. We show in this study that the thrombospondin-1 binding site of calreticulin, spanning aa 19-32, is a major triggering factor for T cell motility and migration within a three-dimensional collagen type 1 matrix, and that exogenous motogenic factors such as chemokines can stimulate migration via a calreticulin-thrombospondin-1 pathway. Endogenous calreticulin binding to the N-terminal domain of endogenous thrombospondin-1 elicited a motogenic signal to the T cells through the C-terminal domain of thrombospondin-1 and its cell surface receptor integrin-associated protein (CD47). Our data further revealed that thrombospondin-1 was expressed on the cell surface with a high turnover, and that PI3K and the Janus family of tyrosine kinases were required for T cell motility mediated through calreticulin, thrombospondin-1, and CD47. These results unveil an autocrine mechanism of calreticulin-thrombospondin-1-CD47 interaction for the control of T cell motility and migration within three-dimensional extracellular matrix substrata.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15634883     DOI: 10.4049/jimmunol.174.2.654

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  25 in total

Review 1.  CD47 update: a multifaceted actor in the tumour microenvironment of potential therapeutic interest.

Authors:  E Sick; A Jeanne; C Schneider; S Dedieu; K Takeda; L Martiny
Journal:  Br J Pharmacol       Date:  2012-12       Impact factor: 8.739

2.  Targeting CD47: the achievements and concerns of current studies on cancer immunotherapy.

Authors:  Yuting Huang; Yuchi Ma; Peng Gao; Zhi Yao
Journal:  J Thorac Dis       Date:  2017-02       Impact factor: 2.895

Review 3.  Thrombospondin1 in tissue repair and fibrosis: TGF-β-dependent and independent mechanisms.

Authors:  Mariya T Sweetwyne; Joanne E Murphy-Ullrich
Journal:  Matrix Biol       Date:  2012-01-14       Impact factor: 11.583

4.  Extranodal dissemination of non-Hodgkin lymphoma requires CD47 and is inhibited by anti-CD47 antibody therapy.

Authors:  Mark P Chao; Chad Tang; Russell K Pachynski; Robert Chin; Ravindra Majeti; Irving L Weissman
Journal:  Blood       Date:  2011-08-09       Impact factor: 22.113

Review 5.  Programmed cell removal: a new obstacle in the road to developing cancer.

Authors:  Mark P Chao; Ravindra Majeti; Irving L Weissman
Journal:  Nat Rev Cancer       Date:  2011-12-08       Impact factor: 60.716

6.  T-cell regulation through a basic suppressive mechanism targeting low-density lipoprotein receptor-related protein 1.

Authors:  Jeneen Panezai; Eva Bergdahl; Karl-Gösta Sundqvist
Journal:  Immunology       Date:  2017-07-10       Impact factor: 7.397

Review 7.  Matricellular protein thrombospondins: influence on ocular angiogenesis, wound healing and immuneregulation.

Authors:  Sharmila Masli; Nader Sheibani; Claus Cursiefen; James Zieske
Journal:  Curr Eye Res       Date:  2014-02-21       Impact factor: 2.424

8.  Thrombospondin-1 is a CD47-dependent endogenous inhibitor of hydrogen sulfide signaling in T cell activation.

Authors:  Thomas W Miller; Sukhbir Kaur; Kelly Ivins-O'Keefe; David D Roberts
Journal:  Matrix Biol       Date:  2013-03-13       Impact factor: 11.583

9.  Deficiency of thrombospondin-1 reduces Th17 differentiation and attenuates experimental autoimmune encephalomyelitis.

Authors:  Kaiyong Yang; Jose L Vega; Muhamed Hadzipasic; Jean Pierre Schatzmann Peron; Bing Zhu; Yijun Carrier; Sharmila Masli; Luiz Vicente Rizzo; Howard L Weiner
Journal:  J Autoimmun       Date:  2009-02-01       Impact factor: 7.094

10.  Prevention of death in bacterium-infected mice by a synthetic antimicrobial peptide, L5, through activation of host immunity.

Authors:  Yukiko Okuyama-Nishida; Nobuko Akiyama; Giichi Sugimori; Kazuhide Nomura; Kenji Ogawa; Koichi J Homma; Kazuhisa Sekimizu; Masafumi Tsujimoto; Shunji Natori
Journal:  Antimicrob Agents Chemother       Date:  2009-03-16       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.